Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

American Capital Commits $212 Mln In One Stop Buyout Of Cambridge Major Labs

RELATED NEWS
Trade ACAS now with 

American Capital Ltd. (ACAS: Quote) announced that it has committed $212 million in the One Stop Buyout of Cambridge Major Laboratories, Inc. or , a global provider of complex chemistry-based outsourcing services to the pharmaceutical and biotechnology industries. CML expands American Capital's portfolio of healthcare products and services companies, which have aggregate revenues of over $600 million.

American Capital's investment took the form of debt and preferred and common equity.

In a separate press release, American Capital announced Thursday that in the fourth quarter of 2012, it made open market purchases of approximately 8.8 million shares of American Capital common stock, or 2.8% of the company's outstanding shares as of September 30, 2012. The shares were purchased at an average price of $11.72 per share, totaling approximately $103 million.

Click here to receive FREE breaking news email alerts for American Capital Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks moved sharply higher over the course of the trading day on Tuesday, extending the recovery from the sell-off seen in recent weeks. The Nasdaq and the S&P 500 closed higher for the fourth consecutive session but remain well off their mid-September highs. Despite indications that the spread of Ebola inside the U.S. has been contained, the results of a new Gallup poll show the deadly disease had made its debut on a list of the top 10 most important problems facing the country. In another hotly contested Senate race, the results of a new Suffolk University/Boston Herald poll show incumbent Sen. Jeanne Shaheen, D-N.H., clinging to a narrow lead over Republican challenger Scott Brown.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.